Accuris Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline H43-A2

Description
Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline
  • Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline - H43-A2 - Accuris
    Accuris
Request a Quote
Description
Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline
Request a Quote

Suppliers

Company
Product
Description
Supplier Links
Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline - H43-A2 - Accuris
Accuris
Englewood, CO, United States
Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline
H43-A2
Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline H43-A2
Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline

Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline

Buy Now

Technical Specifications

  Accuris
Product Category Standards and Technical Documents
Product Number H43-A2
Product Name Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline
Unlock Full Specs
to access all available technical data

Similar Products